How Rising Alpha-1 Antitrypsin Deficiency Awareness is Fueling Market Expansion
The Human Alpha-1 Proteinase Inhibitor Market is witnessing growth due to increasing attention toward alpha-1 antitrypsin deficiency (AATD), a genetic condition that can lead to progressive lung and liver complications. Human alpha-1 proteinase inhibitor therapies are primarily used as augmentation therapy for individuals with severe alpha-1 antitrypsin deficiency and are intended to...
0 Комментарии 0 Поделились 12 Просмотры 0 предпросмотр
G-0QEH8T2MGD